GlassScriptPhysician profile
Mark Roland Nickle
NPI 1134769342
$695.34
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.89 · 2023: $319 · 2024: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $148.77 | 2021-2024 | Jynarque |
| Bard Peripheral Vascular, INC. | $115.64 | 2023 | |
| Amgen INC. | $91.83 | 2021-2024 | Tavneos |
| Horizon Therapeutics Plc | $78.84 | 2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $66.70 | 2021-2024 | Lokelma, Farxiga |
| Novartis Pharmaceuticals Corporation | $53.93 | 2023-2024 | |
| Ani Pharmaceuticals, INC. | $47.63 | 2023-2024 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $34.77 | 2024 | Veltassa |
| Ardelyx, INC. | $22.79 | 2024 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $18.17 | 2024 | |
| Glaxosmithkline, LLC. | $16.27 | 2023 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Nickle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.